Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice
暂无分享,去创建一个
Hongyu Zhao | Ling-Ling Zhu | Tony Yuen | Mone Zaidi | Aiping Lin | Jameel Iqbal | Jun Liu | Hongyu Zhao | T. Yuen | Li Sun | M. Zaidi | Ling-Ling Zhu | P. Mistry | J. Iqbal | A. Lin | Li Sun | Pramod K Mistry | Jun Liu
[1] M. van Eijk,et al. The biology of the Gaucher cell: the cradle of human chitinases. , 2006, International review of cytology.
[2] D. Jain,et al. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis. , 2012, Blood.
[3] R. Stam,et al. Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia , 2012, Leukemia.
[4] B. Ma,et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. , 2011, Annual review of physiology.
[5] E. Sidransky. Gaucher disease and parkinsonism. , 2005, Molecular genetics and metabolism.
[6] B. Aronow,et al. Global gene expression profile progression in Gaucher disease mouse models , 2011, BMC Genomics.
[7] D. Jain,et al. Gaucher disease gene GBA functions in immune regulation , 2012, Proceedings of the National Academy of Sciences.
[8] D. Mahuran,et al. Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. , 2009, Molecular genetics and metabolism.
[9] K. Bove,et al. Pathological findings in Gaucher disease type 2 patients following enzyme therapy. , 1995, Human pathology.
[10] R. Van Tiggelen,et al. Gaucher disease , 2019, Haematology.
[11] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[12] M. Cappellini,et al. A reappraisal of Gaucher disease—diagnosis and disease management algorithms , 2011, American journal of hematology.
[13] Hongyu Zhao,et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage , 2010, Proceedings of the National Academy of Sciences.
[14] A. Mehta. Gaucher disease: unmet treatment needs , 2008, Acta paediatrica.
[15] David S. Wishart,et al. The Online Metabolic and Molecular Bases of Inherited Disease; Chapter 3.1: Metabolism and Metabolic Disease Resources on the Web, Page 1 , 2007 .
[16] F. Choy,et al. Gaucher Disease and Cancer: Concept and Controversy , 2011, International journal of cell biology.
[17] Judy H. Cho,et al. Genome‐wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation , 2012, American journal of hematology.
[18] P. Kaplan,et al. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. , 2011, Blood cells, molecules & diseases.
[19] G. Rennert,et al. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients , 2009, American journal of hematology.
[20] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[21] Alexander A. Morgan,et al. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.
[22] B. Gilburd,et al. Natural autoantibodies in sera of patients with Gaucher's disease , 1995, Journal of Clinical Immunology.